Diabetologia

Papers
(The H4-Index of Diabetologia is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]549
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells261
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]216
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study215
Up Front195
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification167
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes135
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities134
60th EASD Annual Meeting of the European Association for the Study of Diabetes126
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people123
58th EASD Annual Meeting of the European Association for the Study of Diabetes119
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin115
Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT106
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes102
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo95
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care91
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy85
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes81
Ageing well with diabetes: the role of technology79
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)75
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory75
Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies74
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study73
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study72
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials71
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study70
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study66
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq66
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway64
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes61
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation60
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications59
Pinpointing precision medicine for diabetes mellitus59
Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics59
Mortality risk for kidney transplant candidates with diabetes: a population cohort study58
Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults58
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study56
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women56
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk53
Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes53
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy52
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes52
Up Front52
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open52
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap52
Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry52
Daniel Porte Jr, 13 August 1931–13 May 202352
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial51
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study50
Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity50
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy50
0.036900997161865